CWAN

Clearwater Analytics

$24.26

+0.04%
Jun 17, 2026
Bobby Quantitative Model
Clearwater Analytics Holdings, Inc. is a technology company that provides a comprehensive, cloud-based investment accounting and reporting platform primarily for insurance companies, asset managers, hedge funds, and corporate treasuries. It is a market leader in the investment data aggregation and reporting software space, historically focused on back-office functions but has expanded into front- and middle-office capabilities through strategic acquisitions like Enfusion, Beacon, and Bistro. The current investor narrative centers on the company's ongoing integration of these acquisitions to create a unified platform for the entire investment cycle, with recent news highlighting a significant new institutional stake as a vote of confidence, even as the stock has faced headwinds and analyst rating downgrades amid a pending major acquisition.

People also watch

Boost Run Inc. Class A Common Stock

Boost Run Inc. Class A Common Stock

BRUN

Analysis
Sarcos

Sarcos

STRC

Analysis
Applicad

Applicad

APP

Analysis
Salesforce

Salesforce

CRM

Analysis
Uber

Uber

UBER

Analysis

CWAN 12-Month Price Forecast

Historical Price
Current Price $24.26
Average Target $24.26
High Target $27.899
Low Target $20.621000000000002

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Clearwater Analytics's 12-month outlook, with a consensus price target around $31.54 and implied upside of +30.0% versus the current price.

Average Target

$31.54

2 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

2

covering this stock

Price Range

$19 - $32

Analyst target range

Buy
0 (0%)
Hold
1 (50%)
Sell
1 (50%)

Analyst coverage for CWAN appears limited, with only two analysts providing estimates for future EPS and revenue, and no explicit price targets or consensus recommendation provided in the dataset. The institutional ratings data reveals a clear and recent trend of downgrades, with firms like RBC Capital, Morgan Stanley, UBS, Wells Fargo, Piper Sandler, Loop Capital, and Oppenheimer all moving to Neutral/Hold/Equal-Weight or Perform ratings from more bullish stances between December 2025 and February 2026. This pattern signals a significant shift in institutional sentiment from bullish to cautious, likely driven by the stock's run-up, valuation concerns, and execution risks associated with integrating its major acquisitions. The lack of a broad consensus target and the wave of downgrades indicate high uncertainty and a neutral-to-cautious near-term outlook from the analyst community.

Drowning in data?

Find the real signal!

CWAN Technical Analysis

The stock is in a sustained uptrend, evidenced by a 6.62% gain over the past year, though it has significantly underperformed the broader market, as indicated by a -16.24% relative strength versus the SPY. Currently trading at $24.33, the price sits at the 99.6% level of its 52-week range ($15.74 to $24.43), indicating it is pressing against its all-time high resistance. This positioning near the upper bound suggests strong momentum but also raises the risk of a technical pullback if the resistance level holds. Recent momentum has been mixed; the stock is down -4.11% over the past month, diverging negatively from its positive 3-month (+5.01%) and 6-month (+11.55%) trends. This 1-month decline, occurring near the 52-week high, signals a potential consolidation or profit-taking phase after a strong run. The stock's beta of 0.60 indicates it is 40% less volatile than the broader market, which is notable for a technology company and suggests it may be viewed as a relatively defensive holding within the sector. Key technical support is at the 52-week low of $15.74, while immediate resistance is the 52-week high of $24.43; a decisive breakout above $24.43 could signal a continuation of the uptrend, whereas a failure here may lead to a retest of lower support levels.

Beta

0.60

0.60x market volatility

Max Drawdown

-35.8%

Largest decline past year

52-Week Range

$16-$24

Price range past year

Annual Return

+10.1%

Cumulative gain past year

PeriodCWAN ReturnS&P 500
1m-0.6%+0.3%
3m+3.9%+12.3%
6m+9.0%+8.9%
1y+10.1%+24.0%
ytd+0.6%+8.7%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

CWAN Fundamental Analysis

Revenue growth is robust but has shown volatility on a quarterly basis. The most recent Q4 2025 revenue was $217.46 million, representing a significant 71.95% year-over-year increase, primarily driven by acquisitions. However, sequential growth from Q3 ($205.11 million) to Q4 was more modest at 6.0%, indicating a potential normalization post-acquisition surge. The company is not consistently profitable on a GAAP basis, reporting a net loss of -$11.76 million in Q4 2025, translating to a net margin of -5.41%. Gross margins remain strong at 67.24% in Q4, but operating margins have been thin and recently turned positive at 4.95% in Q4, up from 3.20% in Q3, suggesting some operating leverage is being achieved. The balance sheet and cash flow picture is mixed; the company generated positive operating cash flow of $55.33 million in Q4 and has trailing twelve-month free cash flow of $164.29 million, indicating an ability to fund operations internally. However, the debt-to-equity ratio of 0.44 shows a moderate level of leverage, and the return on equity is negative at -1.92%, reflecting the current period of net losses as the company invests for growth.

Quarterly Revenue

$217457000.0B

2025-12

Revenue YoY Growth

+0.71%

YoY Comparison

Gross Margin

+0.67%

Latest Quarter

Free Cash Flow

$164287000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Reportable Segment

Open an Account, get $2 TSLA now!

Valuation Analysis: Is CWAN Overvalued?

Given the company's negative trailing net income, the primary valuation metric selected is the Price-to-Sales (P/S) ratio. The trailing P/S ratio is elevated at 8.95x. The forward P/E ratio of 28.2x is also available, but it is based on estimated future profitability. The stock trades at a significant premium to its own historical sales multiples, which have ranged widely from the mid-30s down to the mid-8s over recent quarters, with the current 8.95x sitting at the lower end of that historical range, suggesting the market has already de-rated the stock from its peak valuation. An industry peer comparison is not available in the provided data, but the high P/S multiple generally implies the market is pricing in strong future growth and margin expansion, contingent on the successful integration of recent acquisitions and a path to sustained profitability.

PE

-168.6x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range -5199x~10108x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

90.0x

Enterprise Value Multiple